Skip to main content
Premium Trial:

Request an Annual Quote

Ezose, Fast Forward Team on MS Biomarker Research

NEW YORK (GenomeWeb News) – Ezose Sciences today said that it will collaborate with Fast Forward, a subsidiary of the National Multiple Sclerosis Society, to discover biomarkers that may help diagnose multiple sclerosis, improve disease management, and help guide development of new MS medicines.

Under the alliance, Ezose will collaborate with Anthony Reder, a professor of neurology at the University of Chicago. Researchers will use Ezose's GlycanMap to discover new biomarkers associated with MS. The GlycanMap platform combines high-throughput glycan enrichment with specialized MALDI-TOF mass spectrometry and bioinformatics to identify and quantitate glycans in complex biological samples.

Pine Brook, NJ-based Ezose said that it will receive up to $390,000 from Fast Forward to support the studies. Further terms were not disclosed.

The Scan

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.

Clinical Genomic Lab Survey Looks at Workforce Needs

Investigators use a survey approach in Genetics in Medicine Open to assess technologist applications, retention, and workforce gaps at molecular genetics and clinical cytogenetics labs in the US.

Study Considers Gene Regulatory Features Available by Sequence-Based Modeling

Investigators in Genome Biology set sequence-based models against observational and perturbation assay data, finding distal enhancer models lag behind promoter predictions.

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.